Laser Photonics Corp (LASE): Nasdaq/NYSE listing notice — Laser Photonics receives Nasdaq deficiency notice for audit committee composition after resignation

Laser Photonics Corp

Received Nasdaq notice on Sept 26, 2023 citing non-compliance with Listing Rule 5605.
Resignation of Ryan Tennyson from board and audit committee on Sept 20, 2023 left audit committee without required independence.
Cure period: until earlier of next annual shareholders' meeting or Sept 20, 2024 (or March 18, 2024 if meeting before then).
Company expects to identify a qualified candidate for the vacancy within the cure period.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Laser Photonics Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(c)(4)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605, 5605(c)(4)

Exact text from the filing

September 26, 2023, the registrant (“Laser Photonics” or the “Company”) received a notice from Nasdaq Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company no longer complies with Nasdaq’s audit committee requirement under Nasdaq’s Listing Rule 5605 following the resignation of Ryan Tennyson from the Company’s board of directors and audit committee effective September 20, 2023. Nasdaq advised Laser Photonics that in accordance with Nasdaq’s Listing Rule 5605(c)(4) the Company has a cure period to regain compliance (i) until the earlier of the Comp

View on SEC.gov

50 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Laser Photonics Corp filing history →

Source: SEC EDGAR

accession 0001654954-23-012439

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.